0 Beoordelingen
ID

23842

Beschrijving

Study part: Exploratory Biomarker Research Week 38 / Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Trefwoorden

Versies (1)
  1. 15-07-17 15-07-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

15 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Exploratory Biomarker Research Week 38 Mepolizumab HES NCT00086658

    Engels

    Exploratory Biomarker Research Week 38

    1 Formulieren  
    EXPLORATORY BIOMARKER RESEARCH
    Beschrijving

    EXPLORATORY BIOMARKER RESEARCH

    Alias
    UMLS CUI-1
    C0005516
    Has the subject provided written consent for exploratory biomarker research?
    Beschrijving

    informed consent biomarker

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0021430
    UMLS CUI [1,2]
    C0005516
    Date of Assessment
    Beschrijving

    Date of Assessment

    Datatype

    date

    Alias
    UMLS CUI [1]
    C2985720
    Date of Assessment Skin Biopsy
    Beschrijving

    Date of Assessment Skin Biopsy

    Datatype

    date

    Alias
    UMLS CUI [1,1]
    C2985720
    UMLS CUI [1,2]
    C0150866
    Date of Assessment GI Biopsy
    Beschrijving

    Date of Assessment GI Biopsy

    Datatype

    date

    Alias
    UMLS CUI [1,1]
    C2985720
    UMLS CUI [1,2]
    C0005558
    UMLS CUI [1,3]
    C0017189
    Terug naar het begin van de pagina

    Similar models

    Exploratory Biomarker Research Week 38

    1 Formulieren
    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    EXPLORATORY BIOMARKER RESEARCH
    C0005516 (UMLS CUI-1)
    informed consent biomarker
    Item
    Has the subject provided written consent for exploratory biomarker research?
    boolean
    C0021430 (UMLS CUI [1,1])
    C0005516 (UMLS CUI [1,2])
    Date of Assessment
    Item
    Date of Assessment
    date
    C2985720 (UMLS CUI [1])
    Date of Assessment Skin Biopsy
    Item
    Date of Assessment Skin Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0150866 (UMLS CUI [1,2])
    Date of Assessment GI Biopsy
    Item
    Date of Assessment GI Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0005558 (UMLS CUI [1,2])
    C0017189 (UMLS CUI [1,3])
    Terug naar het begin van de pagina 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial